Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 6, Number 6, September 2006


Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
pp. 455-489(35)
Authors: Waterhouse, D. N.; Gelmon, K. A.; Klasa, R.; Chi, K.; Huntsman, D.; Ramsay, E.; Wasan, E.; Edwards, L.; Tucker, C.; Zastre, J.; Zhang, Y. Z.; Yapp, D.; Dragowska, W.; Dedha, S.; Bally, M. B.


Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy
pp. 491-517(27)
Authors: Becker, Torsten; Dziadek, Sebastian; Wittrock, Sven; Kunz, Horst


Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
pp. 519-532(14)
Authors: Easty, David; Gallagher, William; Bennett, D. C.


Knowledge of Epigenetic Influence for Prostate Cancer Therapy
pp. 533-551(19)
Authors: Watanabe, Masatoshi; Takagi, Akimitsu; Matsuzaki, Takeshi; Kami, Daisuke; Toyota, Minoru; Hirokawa, Yoshifumi; Shiraishi, Taizo


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more